Skip to main content
San Francisco homeNews home
Story

Danaher Corporation (DHR) Is “Fool’s Gold,” Bemoans Jim Cramer

Ramish Cheema

2 min read

In This Article:

Danaher Corporation (NYSE:DHR) is one of the Jim Cramer Discusses US-China Trade War & These 10 Stocks.

Danaher Corporation (NYSE:DHR) is one of the largest industrial and medical research products manufacturers in America. It has been one of the most troubled stocks this year as the shares have lost 14.5% year-to-date. Danaher Corporation (NYSE:DHR)’s shares dipped by 9.7% in January after the firm missed its fourth-quarter analyst earning estimates which was the first miss in years. It reported $2.14 in earnings and $6.5 billion in revenue while analysts had penciled in $2.16 and $6.4 billion.  Cramer hasn’t been a fan of Danaher Corporation (NYSE:DHR) for the past year or so. Following its quarterly earnings, he called management “smug” and outlined that he had been following Danaher Corporation (NYSE:DHR) for years. Cramer first bought the shares in 2022 and held on to them as believed Danaher Corporation (NYSE:DHR)’s headwinds were temporary. He stuck with the pessimism this time around as well:

“My charitable trust has owned it initially. It was gold now it’s fool’s gold. I’m irate.”

Earlier this year, Cramer shared his discussions with Danaher Corporation (NYSE:DHR)’s management. Here is what he said:

“I think those guys are great—the Rales brothers are amazing. Even when I’m moody, you know, they have Rales stake there and the commander, so I love them even more. But here’s what I mean by that: I want them to show me they understand there’s been some serious underperformance here. They could come back and say, “We’ve outperformed for so many years, Jim, give us patience.” I just want something that shows me they understand we’re getting restless. I think that’s a reasonable thing to say, and I do like them very much.”

Danaher Corporation (DHR) Is "Fool's Gold," Bemoans Jim Cramer

Danaher Corporation (DHR) Is "Fool's Gold," Bemoans Jim Cramer

A healthcare professional in a lab coat holding a microscope and looking at a slide under the lens.

While we acknowledge the potential of DHR as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.

Disclosure: None. This article is originally published at Insider Monkey.